Antitrust Antitrust

Alliance Pharma says it made ‘rational commercial’ decisions, in UK fine appeal

By Jon Menon
  • 27 Jul 2023 16:22
  • 27 Jul 2023 16:22
Alliance Pharmaceuticals has hit back at suggestions it had colluded to break UK competition rules, as several drugmakers begin to close their appeal against fines imposed by the antitrust regulator.

Alliance, Focus, Medreich and Lexon were fined a total of more than 35 million pounds ($43 million) last year by th

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

Latest News